Drug class

LHrH(GNrH) Antagonist, Pituitary Suppressant Agents

The phrase "LHrH(GNrH) Antagonist, Pituitary Suppressant Agents" is a compendial and formulary classification representing gonadotropin-releasing hormone receptor antagonists that directly suppress pituitary gonadotropin secretion. Read more about LHrH(GNrH) Antagonist, Pituitary Suppressant Agents

18 drugs in this class 11 manufacturers

Advertisement

Drugs in LHrH(GNrH) Antagonist, Pituitary Suppressant Agents

Showing 1–9 of 18 drugs

CETROTIDE (cetrorelix acetate)

LHRH(GNRH) ANTAGONIST, PITUITARY SUPPRESSANT AGENTS · PREVENTION OF LUTEINIZING HORMONE SURGE WHEN UNDERGOING CONTROLLED OVARIAN HYPERSTIMULATION
EMD SERONO, INC

FYREMADEL (ganirelix acetate)

LHRH(GNRH) ANTAGONIST, PITUITARY SUPPRESSANT AGENTS · PREVENTION OF LUTEINIZING HORMONE SURGE WHEN UNDERGOING CONTROLLED OVARIAN HYPERSTIMULATION
FERRING PH INC

ORGOVYX (relugolix)

LHRH(GNRH) ANTAGONIST, PITUITARY SUPPRESSANT AGENTS · ADVANCED PROSTATIC CARCINOMA
Sumitomo Pharma America
Filter & compare in the drug finder → Opens the drug finder with LHrH(GNrH) Antagonist, Pituitary Suppressant Agents preselected. Add indication or manufacturer filters there.

About LHrH(GNrH) Antagonist, Pituitary Suppressant Agents.

The phrase "LHrH(GNrH) Antagonist, Pituitary Suppressant Agents" is a compendial and formulary classification representing gonadotropin-releasing hormone receptor antagonists that directly suppress pituitary gonadotropin secretion.

These agents function by competitively binding to pituitary GnRH receptors, which rapidly inhibits the release of luteinizing hormone and follicle-stimulating hormone without inducing the initial hormonal flare associated with agonists.

Medications in this category, such as cetrorelix, ganirelix, and elagolix, are primarily utilized to prevent premature ovulation during assisted reproductive technology cycles and to manage hormone-dependent gynecologic conditions such as moderate to severe endometriosis pain.